GlassScriptPhysician profile
Sarp Aksel
NPI 1245611441
$22,227.58
in general payments reported to CMS, 2019-2025
22 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.21 · 2020: $18.67 · 2021: $160 · 2022: $745 · 2023: $878 · 2024: $1,078 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $6,240 · Food and Beverage: $3,008 · Travel and Lodging: $719 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,232.00 |
| Consulting Fee | $6,240.00 |
| Food and Beverage | $3,007.92 |
| Travel and Lodging | $719.00 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $18,757.22 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $1,028.00 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Mayne Pharma Commercial LLC | $626.65 | 2022-2025 | |
| Exact Sciences Corporation | $259.94 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $204.69 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $168.40 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $146.12 | 2021-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $138.55 | 2025 | Slynd |
| Millicent US INC | $127.08 | 2024-2025 | Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $124.10 | 2022-2025 | |
| Pfizer INC. | $117.95 | 2022-2024 | |
| Therapeuticsmd, INC. | $96.03 | 2020-2022 | |
| Organon LLC | $91.34 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $60.52 | 2024-2025 | Aptima |
| Agile Therapeutics, INC. | $60.18 | 2022-2024 | Twirla |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $50.96 | 2023 | V-Loc 180 |
| Conmed Corporation | $42.49 | 2025 | Airseal |
| Astellas Pharma US INC | $41.90 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $24.89 | 2024 | Ova1 |
| Myovant Sciences INC. | $22.26 | 2022 | |
| Coopersurgical, INC. | $21.97 | 2025 | Paragard T 380a |
| Shield Therapeutics INC | $16.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarp Aksel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.